TTBIO CORP.

TTBIO CORP.

TTPEX:6493
28.05
TWD
0.00
(0.00%)
1.07BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
4.08
3.93
5.95
6.42
9.24
10.92
10.69
7.18
12.25
16.8
12.76
12.52
13.27
- -
Basic EPS, GAAP
-2.55
-2.74
-0.39
0.23
1.1
1.76
1.52
1.84
0.46
1.6
0.27
0.1
-0.71
- -
Free Cash Flow per Basic Share
-14.92
-4.37
0.85
0.35
1.29
-0.2
1.61
-0.83
1.22
0.35
-1.57
0.66
-1.66
- -
Dividend per Share
- -
- -
- -
- -
- -
0.96
1.45
3.38
- -
0.48
1.21
0.29
0.2
- -
Book Value per Share
9.04
10.87
10.59
10.93
11.99
12.84
12.91
11.44
11.85
12.96
12.02
11.84
11.89
12.02
Tangible Book Value per Share
3.28
5.42
5.61
6.28
7.72
8.97
9.44
8.11
8.93
10.35
9.86
10.08
10.8
11.09
Basic Weighted Avg Shares
19
24
25
25
25
25
25
25
25
25
25
25
30
29
Sales/Revenue/Turnover
79
93
148
160
230
272
267
179
306
419
318
312
399
- -
Operating Margin (%)
-63.15
-71.59
-9.42
-0.1
8.26
11.95
9.18
-10.4
4.01
9.16
-0.27
-0.73
-5.21
- -
Depreciation Expense
12
22
25
24
26
29
39
37
37
39
42
39
36
- -
Net Income, GAAP
-50
-65
-10
6
27
44
38
46
12
40
7
3
-21
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
0.28
18.32
17.62
17.46
23.78
- -
- -
Profit Margin (%)
-62.38
-69.62
-6.48
3.53
11.88
16.11
14.25
25.64
3.77
9.5
2.1
0.83
-5.34
- -
Working Capital
33
66
61
101
110
134
115
117
145
179
161
169
238
261
LT Debt
6
21
15
19
13
23
42
38
36
38
48
101
83
90
Total Equity
225
271
264
273
299
320
322
285
295
323
300
295
357
361
Return on Invested Capital (%)
- -
- -
- -
-0.05
- -
- -
- -
-3.61
2.71
7.69
-0.16
-0.36
- -
- -
Return on Capital (%)
- -
- -
- -
2.27
- -
- -
- -
12.66
3.4
10.02
1.97
1.33
- -
- -
Return on Common Equity (%)
-43.96
-26.14
-3.59
2.1
9.58
14.16
11.83
15.11
3.97
12.87
2.14
0.87
-6.53
- -

Capital Structure

TWD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
186
93
161
LT Borrowings
26
26
37
LT Finance Leases
60
56
52
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
25
30
30
Market Capitalization
474
814
1,071

Working Capital

TWD

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
417
411
496
Cash, Cash Equivalents & STI
118
59
92
Accounts Receivable, Net
59
62
111
Inventories
227
280
283
Total Current Liabilities
259
173
235
Payables & Accruals
- -
- -
- -
ST Debt
186
93
161
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.44%
5.05%
21.1%
Free Cash Flow
-237.84%
-281.54%
-402.94%
Net Income, GAAP
-60.26%
-179.32%
-922.39%
Sales/Revenue/Turnover
14.48%
21.94%
27.8%
Total Cash Common Dividend
- -
- -
-16.67%

Semi-annual Revenue

TWD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
312
2025
- -
- -
399
2026
- -
- -
- -

Semi-annual Earnings Per Share

TWD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.1
2025
- -
- -
-0.71
2026
- -
- -
- -

Semi-annual Dividends Per Share

TWD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.29
2025
- -
- -
0.2
2026
- -
- -
- -

Company Description

CEO
Sheng Chieh Su
Full Time Employees
138
Sector
Health technology
Industry
Medical specialties
Address
No. 07, 6th Road Industry Park Taichung TX Taiwan 40755
IPO Date
Jan 8, 2015
Website
ttbio.com
Business
Ttbio Corp. operates both domestically in Taiwan and across global markets, specializing in the creation, distribution, and upkeep of advanced medical equipment under its TTBIO brand. The company primarily offers a diverse range of dental instruments, including high and low-speed handpiece series, essential dental components, service rotors, lubrication systems, and comprehensive electric handpiece setups. Furthermore, Ttbio extends its manufacturing expertise to precision-machined parts and specialized components, catering to critical sectors such as healthcare, automotive, aerospace, security, and computing. Established in 2012, this enterprise is strategically headquartered in Taichung, Taiwan.